CLINICAL_TRIALS
withdrawal
· 2026-01-29
Clinical Trial Update: Effect of Bitopertin on the Liver and on Levels of Protoporphyrin IX in Bile, Blood, Liver, and Stool in Patients With Erythropoietic Protoporphyria/X-linked Protoporphyria and Increased Liver Stiffness and/or Liver Enzymes at Baseline [Phase 1]
Summary
A Phase 1 clinical trial evaluating Bitopertin in patients with erythropoietic protoporphyria or X-linked protoporphyria and baseline liver abnormalities was wi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Protoporphyria | Phase 1 | Status: WITHDRAWN